Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2003 Jul;79(933):391–396. doi: 10.1136/pmj.79.933.391

Acute and chronic arsenic toxicity

R Ratnaike 1
PMCID: PMC1742758  PMID: 12897217

Abstract

Arsenic toxicity is a global health problem affecting many millions of people. Contamination is caused by arsenic from natural geological sources leaching into aquifers, contaminating drinking water and may also occur from mining and other industrial processes. Arsenic is present as a contaminant in many traditional remedies. Arsenic trioxide is now used to treat acute promyelocytic leukaemia. Absorption occurs predominantly from ingestion from the small intestine, though minimal absorption occurs from skin contact and inhalation. Arsenic exerts its toxicity by inactivating up to 200 enzymes, especially those involved in cellular energy pathways and DNA synthesis and repair. Acute arsenic poisoning is associated initially with nausea, vomiting, abdominal pain, and severe diarrhoea. Encephalopathy and peripheral neuropathy are reported. Chronic arsenic toxicity results in multisystem disease. Arsenic is a well documented human carcinogen affecting numerous organs. There are no evidence based treatment regimens to treat chronic arsenic poisoning but antioxidants have been advocated, though benefit is not proven. The focus of management is to reduce arsenic ingestion from drinking water and there is increasing emphasis on using alternative supplies of water.

Full Text

The Full Text of this article is available as a PDF (79.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abernathy C. O., Liu Y. P., Longfellow D., Aposhian H. V., Beck B., Fowler B., Goyer R., Menzer R., Rossman T., Thompson C. Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect. 1999 Jul;107(7):593–597. doi: 10.1289/ehp.99107593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aposhian H. V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol. 1997;37:397–419. doi: 10.1146/annurev.pharmtox.37.1.397. [DOI] [PubMed] [Google Scholar]
  3. Armstrong C. W., Stroube R. B., Rubio T., Siudyla E. A., Miller G. B., Jr Outbreak of fatal arsenic poisoning caused by contaminated drinking water. Arch Environ Health. 1984 Jul-Aug;39(4):276–279. doi: 10.1080/00039896.1984.10545849. [DOI] [PubMed] [Google Scholar]
  4. Axelson O., Dahlgren E., Jansson C. D., Rehnlund S. O. Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter. Br J Ind Med. 1978 Feb;35(1):8–15. doi: 10.1136/oem.35.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beckett W. S., Moore J. L., Keogh J. P., Bleecker M. L. Acute encephalopathy due to occupational exposure to arsenic. Br J Ind Med. 1986 Jan;43(1):66–67. doi: 10.1136/oem.43.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Benowitz N. L. Cardiotoxicity in the workplace. Occup Med. 1992 Jul-Sep;7(3):465–478. [PubMed] [Google Scholar]
  7. Benramdane L., Accominotti M., Fanton L., Malicier D., Vallon J. J. Arsenic speciation in human organs following fatal arsenic trioxide poisoning--a case report. Clin Chem. 1999 Feb;45(2):301–306. [PubMed] [Google Scholar]
  8. Bergstrom S. K., Gillan E., Quinn J. J., Altman A. J. Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case report. J Pediatr Hematol Oncol. 1998 Nov-Dec;20(6):545–547. [PubMed] [Google Scholar]
  9. Borgoño J. M., Vicent P., Venturino H., Infante A. Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant. Environ Health Perspect. 1977 Aug;19:103–105. doi: 10.1289/ehp.19-1637404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Breukink H. J., van Lieshout C. G., van Beukelen P., Jansen H. M. 'Met arsenicum onder dak'. Een geval van arsenicumintoxicatie bij runderen. Tijdschr Diergeneeskd. 1980 May 1;105(9):347–361. [PubMed] [Google Scholar]
  11. Buchet J. P., Lison D., Ruggeri M., Foa V., Elia G. Assessment of exposure to inorganic arsenic, a human carcinogen, due to the consumption of seafood. Arch Toxicol. 1996;70(11):773–778. doi: 10.1007/s002040050339. [DOI] [PubMed] [Google Scholar]
  12. Campbell J. P., Alvarez J. A. Acute arsenic intoxication. Am Fam Physician. 1989 Dec;40(6):93–97. [PubMed] [Google Scholar]
  13. Chiou H. Y., Huang W. I., Su C. L., Chang S. F., Hsu Y. H., Chen C. J. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke. 1997 Sep;28(9):1717–1723. doi: 10.1161/01.str.28.9.1717. [DOI] [PubMed] [Google Scholar]
  14. Chowdhury U. K., Biswas B. K., Chowdhury T. R., Samanta G., Mandal B. K., Basu G. C., Chanda C. R., Lodh D., Saha K. C., Mukherjee S. K. Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ Health Perspect. 2000 May;108(5):393–397. doi: 10.1289/ehp.00108393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Clark D. W. Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drugs. 1985 Apr;29(4):342–375. doi: 10.2165/00003495-198529040-00003. [DOI] [PubMed] [Google Scholar]
  16. Cobo J. M., Castiñeira M. Oxidative stress, mitochondrial respiration, and glycemic control: clues from chronic supplementation with Cr3+ or As3+ to male Wistar rats. Nutrition. 1997 Nov-Dec;13(11-12):965–970. doi: 10.1016/s0899-9007(97)00338-9. [DOI] [PubMed] [Google Scholar]
  17. Concha G., Nermell B., Vahter M. V. Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. Environ Health Perspect. 1998 Jun;106(6):355–359. doi: 10.1289/ehp.98106355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Concha G., Vogler G., Lezcano D., Nermell B., Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci. 1998 Aug;44(2):185–190. doi: 10.1006/toxs.1998.2486. [DOI] [PubMed] [Google Scholar]
  19. Concha G., Vogler G., Lezcano D., Nermell B., Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci. 1998 Aug;44(2):185–190. doi: 10.1006/toxs.1998.2486. [DOI] [PubMed] [Google Scholar]
  20. Edmonds J. S., Francesconi K. A. Transformations of arsenic in the marine environment. Experientia. 1987 May 15;43(5):553–557. doi: 10.1007/BF02143584. [DOI] [PubMed] [Google Scholar]
  21. Everall J. D., Dowd P. M. Influence of environmental factors excluding ultra violet radiation on the incidence of skin cancer. Bull Cancer. 1978;65(3):241–247. [PubMed] [Google Scholar]
  22. Fenaux P., Chomienne C., Degos L. Treatment of acute promyelocytic leukaemia. Best Pract Res Clin Haematol. 2001 Mar;14(1):153–174. doi: 10.1053/beha.2000.0121. [DOI] [PubMed] [Google Scholar]
  23. Fincher R. M., Koerker R. M. Long-term survival in acute arsenic encephalopathy. Follow-up using newer measures of electrophysiologic parameters. Am J Med. 1987 Mar;82(3):549–552. doi: 10.1016/0002-9343(87)90460-8. [DOI] [PubMed] [Google Scholar]
  24. Freeman J. W., Couch J. R. Prolonged encephalopathy with arsenic poisoning. Neurology. 1978 Aug;28(8):853–855. doi: 10.1212/wnl.28.8.853. [DOI] [PubMed] [Google Scholar]
  25. Gebel T. Confounding variables in the environmental toxicology of arsenic. Toxicology. 2000 Apr 3;144(1-3):155–162. doi: 10.1016/s0300-483x(99)00202-4. [DOI] [PubMed] [Google Scholar]
  26. Ghariani M., Adrien M. L., Raucoules M., Bayle J., Jacomet Y., Grimaud D. Intoxication suraiguë à l'arsenic. Ann Fr Anesth Reanim. 1991;10(3):304–307. doi: 10.1016/s0750-7658(05)80838-x. [DOI] [PubMed] [Google Scholar]
  27. Goddard M. J., Tanhehco J. L., Dau P. C. Chronic arsenic poisoning masquerading as Landry-Guillain-Barré syndrome. Electromyogr Clin Neurophysiol. 1992 Sep;32(9):419–423. [PubMed] [Google Scholar]
  28. Goldsmith S., From A. H. Arsenic-induced atypical ventricular tachycardia. N Engl J Med. 1980 Nov 6;303(19):1096–1098. doi: 10.1056/NEJM198011063031905. [DOI] [PubMed] [Google Scholar]
  29. González M. J., Aguilar M. V., Martínez M. C. Mechanisms of absorption of As2O5 from rat small intestine: the effect of different parameters. J Trace Elem Med Biol. 1997 Dec;11(4):239–247. doi: 10.1016/S0946-672X(97)80019-3. [DOI] [PubMed] [Google Scholar]
  30. Greenberg C., Davies S., McGowan T., Schorer A., Drage C. Acute respiratory failure following severe arsenic poisoning. Chest. 1979 Nov;76(5):596–598. doi: 10.1378/chest.76.5.596. [DOI] [PubMed] [Google Scholar]
  31. Guha Mazumder D. N., Haque R., Ghosh N., De B. K., Santra A., Chakraborty D., Smith A. H. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol. 1998 Oct;27(5):871–877. doi: 10.1093/ije/27.5.871. [DOI] [PubMed] [Google Scholar]
  32. Guo H. R., Chiang H. S., Hu H., Lipsitz S. R., Monson R. R. Arsenic in drinking water and incidence of urinary cancers. Epidemiology. 1997 Sep;8(5):545–550. doi: 10.1097/00001648-199709000-00012. [DOI] [PubMed] [Google Scholar]
  33. Han B., Jeng W. L., Chen R. Y., Fang G. T., Hung T. C., Tseng R. J. Estimation of target hazard quotients and potential health risks for metals by consumption of seafood in Taiwan. Arch Environ Contam Toxicol. 1998 Nov;35(4):711–720. doi: 10.1007/s002449900535. [DOI] [PubMed] [Google Scholar]
  34. Hood R. D., Vedel-Macrander G. C. Evaluation of the effect of BAL (2,3-dimercaptopropanol) on arsenite-induced teratogenesis in mice. Toxicol Appl Pharmacol. 1984 Mar 30;73(1):1–7. doi: 10.1016/0041-008x(84)90045-0. [DOI] [PubMed] [Google Scholar]
  35. Hopenhayn-Rich C., Biggs M. L., Smith A. H. Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina. Int J Epidemiol. 1998 Aug;27(4):561–569. doi: 10.1093/ije/27.4.561. [DOI] [PubMed] [Google Scholar]
  36. Hopenhayn-Rich C., Smith A. H., Goeden H. M. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res. 1993 Feb;60(2):161–177. doi: 10.1006/enrs.1993.1024. [DOI] [PubMed] [Google Scholar]
  37. Hsueh Y. M., Wu W. L., Huang Y. L., Chiou H. Y., Tseng C. H., Chen C. J. Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis. 1998 Dec;141(2):249–257. doi: 10.1016/s0021-9150(98)00178-6. [DOI] [PubMed] [Google Scholar]
  38. Kew J., Morris C., Aihie A., Fysh R., Jones S., Brooks D. Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ. 1993 Feb 20;306(6876):506–507. doi: 10.1136/bmj.306.6876.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Kingston R. L., Hall S., Sioris L. Clinical observations and medical outcome in 149 cases of arsenate ant killer ingestion. J Toxicol Clin Toxicol. 1993;31(4):581–591. doi: 10.3109/15563659309025763. [DOI] [PubMed] [Google Scholar]
  40. Ko R. J. Causes, epidemiology, and clinical evaluation of suspected herbal poisoning. J Toxicol Clin Toxicol. 1999;37(6):697–708. doi: 10.1081/clt-100102447. [DOI] [PubMed] [Google Scholar]
  41. Kurttio P., Pukkala E., Kahelin H., Auvinen A., Pekkanen J. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect. 1999 Sep;107(9):705–710. doi: 10.1289/ehp.99107705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Lander J. J., Stanley R. J., Sumner H. W., Boswell D. C., Aach R. D. Angiosarcoma of the liver associated with Fowler's solution (potassium arsenite). Gastroenterology. 1975 Jun;68(6):1582–1586. [PubMed] [Google Scholar]
  43. Le Quesne P. M. Metal-induced diseases of the nervous system. Br J Hosp Med. 1982 Nov;28(5):534–538. [PubMed] [Google Scholar]
  44. Lee-Feldstein A. A comparison of several measures of exposure to arsenic. Matched case-control study of copper smelter employees. Am J Epidemiol. 1989 Jan;129(1):112–124. doi: 10.1093/oxfordjournals.aje.a115100. [DOI] [PubMed] [Google Scholar]
  45. Lerman B. B., Ali N., Green D. Megaloblastic, dyserythropoietic anemia following arsenic ingestion. Ann Clin Lab Sci. 1980 Nov-Dec;10(6):515–517. [PubMed] [Google Scholar]
  46. Lewis D. R., Southwick J. W., Ouellet-Hellstrom R., Rench J., Calderon R. L. Drinking water arsenic in Utah: A cohort mortality study. Environ Health Perspect. 1999 May;107(5):359–365. doi: 10.1289/ehp.99107359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Lien H. C., Tsai T. F., Lee Y. Y., Hsiao C. H. Merkel cell carcinoma and chronic arsenicism. J Am Acad Dermatol. 1999 Oct;41(4):641–643. [PubMed] [Google Scholar]
  48. Logemann E., Krützfeldt B., Pollak S. Suizidale Einnahme von elementarem Arsen. Arch Kriminol. 1990 Mar-Apr;185(3-4):80–88. [PubMed] [Google Scholar]
  49. Lorenzo H. K., Susin S. A., Penninger J., Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ. 1999 Jun;6(6):516–524. doi: 10.1038/sj.cdd.4400527. [DOI] [PubMed] [Google Scholar]
  50. Matschullat J. Arsenic in the geosphere--a review. Sci Total Environ. 2000 Apr 17;249(1-3):297–312. doi: 10.1016/s0048-9697(99)00524-0. [DOI] [PubMed] [Google Scholar]
  51. Mazumder D. N., Das Gupta J., Santra A., Pal A., Ghose A., Sarkar S. Chronic arsenic toxicity in west Bengal--the worst calamity in the world. J Indian Med Assoc. 1998 Jan;96(1):4-7, 18. [PubMed] [Google Scholar]
  52. Mazumder D. N., Haque R., Ghosh N., De B. K., Santra A., Chakraborti D., Smith A. H. Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int J Epidemiol. 2000 Dec;29(6):1047–1052. doi: 10.1093/ije/29.6.1047. [DOI] [PubMed] [Google Scholar]
  53. McLellan Faith. Arsenic contamination affects millions in Bangladesh. Lancet. 2002 Mar 30;359(9312):1127–1127. doi: 10.1016/S0140-6736(02)08179-5. [DOI] [PubMed] [Google Scholar]
  54. McLellan Faith. Arsenic contamination affects millions in Bangladesh. Lancet. 2002 Mar 30;359(9312):1127–1127. doi: 10.1016/S0140-6736(02)08179-5. [DOI] [PubMed] [Google Scholar]
  55. Mitchell-Heggs C. A., Conway M., Cassar J. Herbal medicine as a cause of combined lead and arsenic poisoning. Hum Exp Toxicol. 1990 May;9(3):195–196. doi: 10.1177/096032719000900314. [DOI] [PubMed] [Google Scholar]
  56. Morton W. E., Caron G. A. Encephalopathy: an uncommon manifestation of workplace arsenic poisoning? Am J Ind Med. 1989;15(1):1–5. doi: 10.1002/ajim.4700150102. [DOI] [PubMed] [Google Scholar]
  57. Mueller P. D., Benowitz N. L. Toxicologic causes of acute abdominal disorders. Emerg Med Clin North Am. 1989 Aug;7(3):667–682. [PubMed] [Google Scholar]
  58. Mäki-Paakkanen J., Kurttio P., Paldy A., Pekkanen J. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ Mol Mutagen. 1998;32(4):301–313. doi: 10.1002/(sici)1098-2280(1998)32:4<301::aid-em3>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  59. Neshiwat L. F., Friedland M. L., Schorr-Lesnick B., Feldman S., Glucksman W. J., Russo R. D., Jr Hepatic angiosarcoma. Am J Med. 1992 Aug;93(2):219–222. doi: 10.1016/0002-9343(92)90054-f. [DOI] [PubMed] [Google Scholar]
  60. Nevens F., Staessen D., Sciot R., Van Damme B., Desmet V., Fevery J., De Groote J., Van Steenbergen W. Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. Gastroenterology. 1994 Feb;106(2):459–463. doi: 10.1016/0016-5085(94)90605-x. [DOI] [PubMed] [Google Scholar]
  61. Nickson R., McArthur J., Burgess W., Ahmed K. M., Ravenscroft P., Rahman M. Arsenic poisoning of Bangladesh groundwater. Nature. 1998 Sep 24;395(6700):338–338. doi: 10.1038/26387. [DOI] [PubMed] [Google Scholar]
  62. Ong E. S., Yong Y. L., Woo S. O. Determination of arsenic in traditional Chinese medicine by microwave digestion with flow injection-inductively coupled plasma mass spectrometry (FI-ICP-MS). J AOAC Int. 1999 Jul-Aug;82(4):963–967. [PubMed] [Google Scholar]
  63. Pinto S. S., Enterline P. E., Henderson V., Varner M. O. Mortality experience in relation to a measured arsenic trioxide exposure. Environ Health Perspect. 1977 Aug;19:127–130. doi: 10.1289/ehp.7719127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Poklis A., Saady J. J. Arsenic poisoning: acute or chronic? Suicide or murder? Am J Forensic Med Pathol. 1990 Sep;11(3):226–232. [PubMed] [Google Scholar]
  65. Prystowsky S. D., Elfenbein G. J., Lamberg S. I. Nasopharyngeal cardcinoma associated with long-term arsenic ingestion. Arch Dermatol. 1978 Apr;114(4):602–603. [PubMed] [Google Scholar]
  66. Quatrehomme G., Ricq O., Lapalus P., Jacomet Y., Ollier A. Acute arsenic intoxication: forensic and toxicologic aspects (an observation). J Forensic Sci. 1992 Jul;37(4):1163–1171. [PubMed] [Google Scholar]
  67. Rahman M. M., Chowdhury U. K., Mukherjee S. C., Mondal B. K., Paul K., Lodh D., Biswas B. K., Chanda C. R., Basu G. K., Saha K. C. Chronic arsenic toxicity in Bangladesh and West Bengal, India--a review and commentary. J Toxicol Clin Toxicol. 2001;39(7):683–700. doi: 10.1081/clt-100108509. [DOI] [PubMed] [Google Scholar]
  68. Rahman M., Tondel M., Ahmad S. A., Axelson O. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol. 1998 Jul 15;148(2):198–203. doi: 10.1093/oxfordjournals.aje.a009624. [DOI] [PubMed] [Google Scholar]
  69. Rahman M., Tondel M., Ahmad S. A., Chowdhury I. A., Faruquee M. H., Axelson O. Hypertension and arsenic exposure in Bangladesh. Hypertension. 1999 Jan;33(1):74–78. doi: 10.1161/01.hyp.33.1.74. [DOI] [PubMed] [Google Scholar]
  70. Regelson W., Kim U., Ospina J., Holland J. F. Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler's solution. Cancer. 1968 Mar;21(3):514–522. doi: 10.1002/1097-0142(196803)21:3<514::aid-cncr2820210323>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  71. Saady J. J., Blanke R. V., Poklis A. Estimation of the body burden of arsenic in a child fatally poisoned by arsenite weedkiller. J Anal Toxicol. 1989 Sep-Oct;13(5):310–312. doi: 10.1093/jat/13.5.310. [DOI] [PubMed] [Google Scholar]
  72. Santra A., Das Gupta J., De B. K., Roy B., Guha Mazumder D. N. Hepatic manifestations in chronic arsenic toxicity. Indian J Gastroenterol. 1999 Oct-Nov;18(4):152–155. [PubMed] [Google Scholar]
  73. Schenk V. W., Stolk P. J. Psychosis following arsenic (possibly thallium) poisoning. A clinical-neuropathological report. Psychiatr Neurol Neurochir. 1967 Jan-Feb;70(1):31–37. [PubMed] [Google Scholar]
  74. Schoolmeester W. L., White D. R. Arsenic poisoning. South Med J. 1980 Feb;73(2):198–208. doi: 10.1097/00007611-198002000-00021. [DOI] [PubMed] [Google Scholar]
  75. Shen Z. X., Chen G. Q., Ni J. H., Li X. S., Xiong S. M., Qiu Q. Y., Zhu J., Tang W., Sun G. L., Yang K. Q. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood. 1997 May 1;89(9):3354–3360. [PubMed] [Google Scholar]
  76. Shen Z. X., Chen G. Q., Ni J. H., Li X. S., Xiong S. M., Qiu Q. Y., Zhu J., Tang W., Sun G. L., Yang K. Q. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood. 1997 May 1;89(9):3354–3360. [PubMed] [Google Scholar]
  77. Shen Z. Y., Tan L. J., Cai W. J., Shen J., Chen C., Tang X. M., Zheng M. H. Arsenic trioxide induces apoptosis of oesophageal carcinoma in vitro. Int J Mol Med. 1999 Jul;4(1):33–37. doi: 10.3892/ijmm.4.1.33. [DOI] [PubMed] [Google Scholar]
  78. Silver S., Misra T. K. Bacterial transformations of and resistances to heavy metals. Basic Life Sci. 1984;28:23–46. doi: 10.1007/978-1-4684-4715-6_3. [DOI] [PubMed] [Google Scholar]
  79. Smith A. H., Arroyo A. P., Mazumder D. N., Kosnett M. J., Hernandez A. L., Beeris M., Smith M. M., Moore L. E. Arsenic-induced skin lesions among Atacameño people in Northern Chile despite good nutrition and centuries of exposure. Environ Health Perspect. 2000 Jul;108(7):617–620. doi: 10.1289/ehp.00108617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Soignet S. L., Maslak P., Wang Z. G., Jhanwar S., Calleja E., Dardashti L. J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D. A. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med. 1998 Nov 5;339(19):1341–1348. doi: 10.1056/NEJM199811053391901. [DOI] [PubMed] [Google Scholar]
  81. Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Snow B. E., Brothers G. M., Mangion J., Jacotot E., Costantini P., Loeffler M. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999 Feb 4;397(6718):441–446. doi: 10.1038/17135. [DOI] [PubMed] [Google Scholar]
  82. Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Snow B. E., Brothers G. M., Mangion J., Jacotot E., Costantini P., Loeffler M. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999 Feb 4;397(6718):441–446. doi: 10.1038/17135. [DOI] [PubMed] [Google Scholar]
  83. Sutherland D., Swash P. M., Macqueen A. C., McWilliam L. E., Ross D. J., Wood S. C. A field based evaluation of household arsenic removal technologies for the treatment of drinking water. Environ Technol. 2002 Dec;23(12):1385–1403. doi: 10.1080/09593332508618444. [DOI] [PubMed] [Google Scholar]
  84. Tamaki S., Frankenberger W. T., Jr Environmental biochemistry of arsenic. Rev Environ Contam Toxicol. 1992;124:79–110. doi: 10.1007/978-1-4612-2864-6_4. [DOI] [PubMed] [Google Scholar]
  85. Thomas K. W., Pellizzari E. D., Berry M. R. Population-based dietary intakes and tap water concentrations for selected elements in the EPA region V National Human Exposure Assessment Survey (NHEXAS). J Expo Anal Environ Epidemiol. 1999 Sep-Oct;9(5):402–413. doi: 10.1038/sj.jea.7500051. [DOI] [PubMed] [Google Scholar]
  86. Thompson D. J. A chemical hypothesis for arsenic methylation in mammals. Chem Biol Interact. 1993 Sep;88(2-3):89–14. doi: 10.1016/0009-2797(93)90086-e. [DOI] [PubMed] [Google Scholar]
  87. Treleaven J., Meller S., Farmer P., Birchall D., Goldman J., Piller G. Arsenic and Ayurveda. Leuk Lymphoma. 1993 Jul;10(4-5):343–345. doi: 10.3109/10428199309148558. [DOI] [PubMed] [Google Scholar]
  88. Tripathi R. M., Raghunath R., Krishnamoorthy T. M. Arsenic intake by the adult population in Bombay city. Sci Total Environ. 1997 Dec 3;208(1-2):89–95. doi: 10.1016/s0048-9697(97)00278-7. [DOI] [PubMed] [Google Scholar]
  89. Tsai S. M., Wang T. N., Ko Y. C. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch Environ Health. 1999 May-Jun;54(3):186–193. doi: 10.1080/00039899909602258. [DOI] [PubMed] [Google Scholar]
  90. Wilkinson S. P., McHugh P., Horsley S., Tubbs H., Lewis M., Thould A., Winterton M., Parsons V., Williams R. Arsine toxicity aboard the Asiafreighter. Br Med J. 1975 Sep 6;3(5983):559–563. doi: 10.1136/bmj.3.5983.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Wong S. S., Tan K. C., Goh C. L. Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):179–185. doi: 10.1016/s0190-9622(98)70596-1. [DOI] [PubMed] [Google Scholar]
  92. Wong S. T., Chan H. L., Teo S. K. The spectrum of cutaneous and internal malignancies in chronic arsenic toxicity. Singapore Med J. 1998 Apr;39(4):171–173. [PubMed] [Google Scholar]
  93. Yuan Tao, Hu Jiang Yong, Ong Say Leong, Luo Qi Fang, Ng Wern Jun. Arsenic removal from household drinking water by adsorption. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2002 Oct;37(9):1721–1736. doi: 10.1081/ese-120015432. [DOI] [PubMed] [Google Scholar]
  94. Zaw Myint, Emett Maree T. Arsenic removal from water using advanced oxidation processes. Toxicol Lett. 2002 Jul 7;133(1):113–118. doi: 10.1016/s0378-4274(02)00081-4. [DOI] [PubMed] [Google Scholar]
  95. Zhu Jun, Chen Zhu, Lallemand-Breitenbach Valérie, de Thé Hugues. How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer. 2002 Sep;2(9):705–713. doi: 10.1038/nrc887. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES